|
Assay |
Type of Change |
|
Soluble Transferrin Receptors (sTfR) |
Changes to Reference Ranges |
|
Lead
(blood) |
Change to Reference Ranges, Changes to Patient Management |
|
Molecular Haematology |
Added Turnaround Times |
|
Metanephrines |
Addition to Diagnostic Use |
|
Homocysteine |
Additions to Diagnostic Use |
|
Angiotensin Converting Enzyme |
Added CSF |
|
Clozapine |
Change to Turnaround time |
|
Tissue transglutaminase autoantibodies |
New preferred sample type |
|
Allergy
Tests |
New preferred sample type |
|
IgE total |
New preferred sample type |
|
Tryptase |
New preferred sample type |
|
Thyroid autoantibodies |
New preferred sample type |
|
Parietal and intrinsic factor antibodies |
New preferred sample type |
|
Anti-cyclic citrullinated peptide (CCP) |
New preferred sample type |
|
Cardiolipin Autoantibodies |
New preferred sample type |
|
Pneumococcal serology |
New preferred sample type |
|
Beta-2-glycoprotein |
New preferred sample type |
|
Varicella Zoster Virus |
New preferred sample type |
|
Tetanus serology |
New preferred sample type |
|
Bordetella pertussis |
New preferred sample type |
|
Parvovirus |
New preferred sample type |
|
Complement |
New preferred sample type |
|
Streptococcal serology |
New preferred sample type |
|
Protein electrophoresis |
New preferred sample type |
|
Entamoeba histolytica antibodies |
New preferred sample type |
|
dsDNA antibodies |
New preferred sample type |
|
ENA antibodies |
New preferred sample type |
|
Glomerular basement membrane antibodies |
New preferred sample type |
|
Liver kidney microsomal antibodies |
New preferred sample type |
|
Soluble liver antigen antibodies |
New preferred sample type |
|
Tissue autoantibodies |
New preferred sample type |
|
Skin autoantibodies |
New preferred sample type |
|
Transferrin isoforms |
New preferred sample type |
|
Treponema serology |
New preferred sample type |
|
Avian precipitins |
New preferred sample type |
|
Micropolysporia faeni serology |
New preferred sample type |
|
Cystatin C |
New preferred sample type |
|
Beta 2 microglobulin |
New preferred sample type |
|
Cytomegalovirus (CMV) |
New preferred sample type |
|
Dengue |
New preferred sample type |
|
Diphtheria toxoid IgG |
New preferred sample type |
|
Epstein Barr virus |
New preferred sample type |
|
Helicobacter pylori |
New preferred sample type |
|
Haemophilus influenzae IgG |
New preferred sample type |
|
Measles
virus |
New preferred sample type |
|
Mumps |
New preferred sample type |
|
Mycoplasma pneumoniae |
New preferred sample type |
|
ANCA (Anti-neutrophil cytoplasmic antibodies) |
New preferred sample type |
|
ANA (Antinuclear antibodies) |
New preferred sample type |
|
Acetylcholine receptor antibody |
New preferred sample type |
|
Influenza A and B |
New preferred sample type |
|
Adenovirus |
New preferred sample type |
|
Respiratory virus screen |
New preferred sample type |
|
Coxiella burnetti |
New preferred sample type |
|
Legionella serology |
New preferred sample type |
|
Hydatid serology |
New preferred sample type |
|
Enterovirus |
New preferred sample type |
|
Chlamydia pneumoniae |
New preferred sample type |
|
Brucellosis |
New preferred sample type |
|
Borrelia serology |
New preferred sample type |
|
Cat
scratch disease |
New preferred sample type |
|
Rheumatoid factor |
New preferred sample type |
|
Immunoglobulins |
New preferred sample type |
|
Immunoglobulin subclasses |
New preferred sample type |
|
Hepatitis serology |
New preferred sample type |
|
Maternal Serum Screen |
Many Changes |
|
Urate |
Reference Range Change |
|
Oxalate
plasma
new |
New Test |
|
Mercury
(urine) |
Change to Specimen and Reference Intervals |
|
Mercury
(blood) |
Change to range |
|
Heparin
Therapy |
Many Changes |
|
Ceruloplasmin |
New preferred sample type |
|
C 1 Inhibitor Deficiency |
New preferred sample type |
|
alpha - 1 - antitrypsin and phenotyping |
New preferred sample type |
|
Toxoplasma gondii |
New preferred sample type |
|
Rubella virus |
New preferred sample type |
|
HIV |
New preferred sample type |
|
Myoglobin |
Change to Reference Interval |
|
Lamotrigine |
Change to Therapeutic Range |
|
Fat
Globules |
This test has been replaced by the
Steatocrit test |
|
Lactate Dehydrogenase |
Change to Reference Interval |
|
Metanephrines
new |
New Topic |
|
Varicella Zoster Virus |
Change to DNA Specimen Requirements |
|
Xanthochromia |
Additional Specimen Requirements |
|
Red
Cell Folate |
Stability of Sample added |
|
Fanconi Anaemia |
Changes to Sample Requirements, Test Performed, Referral Laboratory,
Collection Day and Time. |
